Eventide Asset Management, LLC Arvinas, Inc. Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $11.8 Million - $16.3 Million
281,500 New
281,500 $12.5 Million
Q4 2020

Feb 16, 2021
SELL
$20.19 - $84.93 $4.64 Million - $19.5 Million
-230,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$33.0 - $54.5 $7.59 Million - $12.5 Million
230,000 New
230,000 $9.27 Million

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $997M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email